DuPont de Nemours, Inc. Healthcare & Water Technologies — Research and development expenses increased by 10.0% to $22.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 10.0%, from $20.00M to $22.00M.
Higher R&D spending typically signals a commitment to long-term innovation, though it may temporarily depress current operating margins.
Expenditures dedicated to the discovery, development, and improvement of products and technologies within the Healthcare...
Standard R&D metric for technology-driven or specialty chemical companies.
dd_segment_healthcare_water_technologies_research_and_development_expenses| Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Value | $18.75M | $18.75M | $18.75M | $18.75M | $21.00M | $21.00M | $21.00M | $21.00M | $20.00M | $22.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +12.0% | +0.0% | +0.0% | +0.0% | -4.8% | +10.0% |
| YoY Change | — | — | — | — | +12.0% | +12.0% | +12.0% | +12.0% | -4.8% | +10.0% |